Neurobit Secures US Utility Patent for AI-Powered Diagnostic System

NEW YORK - Aug. 25, 2025 - PRLog -- Neurobit, a leader in AI-driven healthcare solutions, announced that it has been granted a United States Utility Patent for its innovative computer-implemented system for diagnosing sleep disorders. The patented system dramatically improves diagnostic efficiency in hospitals and clinics by combining AI automation with secure, scalable deployment options.

Deployed through Neurobit PSG, already used by more than 170 universities and research institutions worldwide, the system reduces analysis time, minimizes variability, and integrates seamlessly with existing healthcare infrastructures.

"This patent marks a pivotal step in bringing AI into mainstream healthcare," said Kishan, CEO of Neurobit. "Our goal is to equip hospitals and clinics with advanced tools that deliver faster, more precise diagnostics and improve patient outcomes."

Patent Title: System and Method for Computer-Implemented Diagnosis of Sleep Disorders

The technology is available for licensing through Neurobit PSG, enabling healthcare providers and researchers to benefit from next-generation AI-powered diagnostics.

For more information, visit: www.neurobit.com/psg